LCID
Lucid Group, Inc.
LCID has a slight edge over SG overall, supported by stronger fundamentals and lower modeled downside.
SG
Sweetgreen, Inc.
SG offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
SG's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $9.04 | -27% |
| Fair | 73x | $10.88 | -12% |
| Current | 83x | $12.38 | — |
| Expensive | 86x | $12.94 | +4.5% |
Historical ranges are pointers, not guarantees.
SG's PE is 83x, but its earnings don't support one, so it isn't a reliable read right now.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect SG's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.15 | +$1.12 |
| Q2 2026 | $0.10 | +$0.94 |
| Q1 2026 | $0.12 | +$0.89 |
| Q4 2025 | -$1.14 | -$0.35 |
| Q3 2025 | -$0.97 | -$0.18 |
| Q2 2025 | -$0.84 | -$0.01 |
| Q1 2025 | -$0.77 | +$0.17 |
| Q4 2024 | -$0.79 | +$0.22 |
SG has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $176M | +2.1% |
| Q2 2026 | $192.7M | +3.8% |
| Q1 2026 | $161.5M | -2.9% |
| Q4 2025 | $155.2M | -3.5% |
| Q3 2025 | $172.4M | -0.6% |
| Q2 2025 | $185.6M | +0.5% |
| Q1 2025 | $166.3M | +5.4% |
| Q4 2024 | $160.9M | +5.1% |
SG's revenue grew through 2024 and has held roughly level since: $176M last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -18% | +3 points |
| Q2 2026 | -14% | 0 points |
| Q1 2026 | -21% | -4.1 points |
| Q4 2025 | -31% | -11 points |
| Q3 2025 | -21% | -8.8 points |
| Q2 2025 | -14% | -5.5 points |
| Q1 2025 | -17% | -0.1 points |
| Q4 2024 | -20% | -0.4 points |
SG has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$22.1M | +$15.1M |
| Q2 2026 | -$10.6M | +$2.6M |
| Q1 2026 | -$29.6M | +$302K |
| Q4 2025 | -$39M | -$18.4M |
| Q3 2025 | -$37.2M | -$26.9M |
| Q2 2025 | -$13.1M | -$13M |
| Q1 2025 | -$29.9M | -$19.9M |
| Q4 2024 | -$20.6M | -$14.7M |
SG has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +212K shares |
| 1 year | +0.7% | +828K shares |
| 3 years | +6.2% | +6.9M shares |
| 5 years | +10% | +10.9M shares |
| Available history | +10% | +10.9M shares |
SG has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SG Net Leverage
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 72.3 | Overbought |
| Stochastic | 88.8 | Overbought |
SG's weekly RSI is 72 (overbought) and its Stochastic is 89 (overbought).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SG PE vs Consumer Cyclical Sector
| Metric | SG | Sector median | Relative |
|---|---|---|---|
| PE | 83x | 18x | 358% above |
| PE % | 78 | 56 | 22 pts above |
SG is trading at 83x earnings, a 358% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 20% above |
| 20 week MA | $8.29 | 49% above |
| 50 week MA | $7.50 | 65% above |
| 100 week MA | $12.2 | 1.7% above |
| 200 week MA | $15.7 | 21% below |
SG has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $53.0 | $31.4 | -41% |
| 2022 | $31.4 | $8.83 | -72% |
| 2023 | $8.83 | $11.3 | +28% |
| 2024 | $11.3 | $32.4 | +186% |
| 2025 | $32.4 | $6.97 | -78% |
| 2026 YTD | $6.97 | $12.4 | +78% |
SG has the edge over LCID on returns for 2026, with the stronger performance.